October 4, 2018 / 5:18 PM / 2 months ago

BRIEF-FDA Approves Genentech’S Hemlibra For Hemophilia A Without Factor Viii Inhibitors

Oct 4 (Reuters) - Genentech:

* FDA APPROVES GENENTECH'S HEMLIBRA (EMICIZUMAB-KXWH) FOR HEMOPHILIA A WITHOUT FACTOR VIII INHIBITORS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below